Semantic Clinical Drug (SCD):
Influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 mg/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 mg/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 mg/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 mg/ML Injectable Suspension
(Atom ID: 12750301)
Clinical Status & Identity
Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza A virus A/Darwin/11/2021 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Delaware/55/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML / influenza B virus B/Singapore/WUH4618/2021 antigen 0.03 MG/ML Injectable Suspension
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.
Interoperability & Coding
Concept ID (RxCUI)
2605737
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12750301
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
2605737
The "Most useful" identifier asserted by the original source vocabulary.
Source & Registry Data
Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
Technical Attributes & Logic
RXN AI
{2056526} 2056525
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2605726} 2605723
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2605727} 2605724
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2605728} 2605725
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2056526} 2056525
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2605726} 2605723
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2605727} 2605724
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2605728} 2605725
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
0.03 MG/ML (expressed as influenza A virus A/Darwin/11/2021 (H3N2) antigen) / 0.03 MG/ML (expressed as influenza A virus A/Delaware/55/2019 (H1N1) antigen) / 0.03 MG/ML (expressed as influenza B virus B/Singapore/INFTT-16-0610/2016 antigen) / 0.03 MG/ML (expressed as influenza B virus B/Singapore/WUH4618/2021 antigen)
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{2056526} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2605726} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2605727} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2605728} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Susp
The RxTerm dose form name for this drug
